Some biosimilars are approved for treating ulcerative colitis (UC). Learn how these medications can fit into your ulcerative colitis management.

Since Amjevita is a biosimilar of Humira, they share some of the same side effects. For example, injection site reactions, such as swelling and itching, are a common side effect seen with both drugs.

All biologics that treat autoimmune diseases carry the potential for serious side effects. Of the 23 marketed since 1998, 13 got "black box" warnings, the most stringent issued by the U.S. Food ...

ADVERSE REACTIONS The most common adverse reactions in adalimumab clinical trials (>10%) were: infections (e.g., upper respiratory, sinusitis), injection site reactions, headache, and rash.

Of those in the Humira group, 30 patients (7.9%) stopped treatment after 12 months. Sixteen (53.3%) did so because of insufficient effect, seven (23.3%) because of adverse events and seven (23.3% ...

Jan. 2, 2003 — Abbott Laboratories received U.S. Food and Drug Administration (FDA) approval this week to market adalimumab (Humira), previously known as D2E7. The drug was approved for the ...

Adverse events related to use of adalimumab should be reported to Abbott at 1-800-633-9110.

At 24 months, overall safety data were similar for both groups, including frequency of adverse events (92.8% and 91.5%), serious adverse events (13.8% and 16.5%), and malignancies (2.2% and 2.1% ...